1. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver
Dam Eye Study. Ophthalmology. 1992;99(6):933-43.
2. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv
Ophthalmol.1988;32(6):375-413. Review.
3. Atlas d’angiographie. Y. Cohen, Masson
4. Sarraf D, Gin T, Yu F, Brannon A, Owens SL, Bird AC. Long-term drusen study.
Retina. 1999;19(6):513-9.
5. Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation:
II. A surgical approach for age-related macular degeneration? Graefes Arch Clin Exp
Ophthalmol. 1993;231(11):635-41.
6. Binder S, Stolba U, Krebs I, Kellner L, Jahn C, Feichtinger H, Povelka M, Frohner U,
Kruger A, Hilgers RD, Krugluger W. Transplantation of autologous retinal pigment
epithelium in eyes with foveal neovascularization resulting from age-related macular
degeneration: a pilot study. Am J Ophthalmol. 2002;133(2):215-25.
7. A prospective, randomized, double-masked trial on radiation therapy for neovascular
age-related macular degeneration (RAD Study). Radiation Therapy for Age-related
Macular Degeneration. Ophthalmology. 1999;106(12):2239-47.
8. Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal
choroidal neovascularization secondary to age-related macular degeneration: phase II
study results. Ophthalmology. 2003;110(5):979-86.
9. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled,
clinical trial of high-dose supplementation with vitamins C and E and beta carotene
for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol.
2001;119(10):1439-52.